First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Shares Down 0.1% - Here's Why

Key Points

• The First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) experienced a minor drop of 0.1% during mid-day trading, closing at GBX 1,589.80 ($21.36).
• Trading volume surged to 99,769 shares, reflecting a remarkable increase of 1,264% compared to its average session volume of 7,312 shares.
• The ETF has a market capitalization of £652.16 million and a notably high PE ratio of -1,445.27.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report)'s share price dropped 0.1% during trading on Thursday . The company traded as low as GBX 1,589.80 ($21.52) and last traded at GBX 1,589.80 ($21.52). Approximately 99,769 shares were traded during trading, an increase of 1,264% from the average daily volume of 7,312 shares. The stock had previously closed at GBX 1,591.60 ($21.54).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.0%

The stock has a market cap of £656.83 million and a price-to-earnings ratio of -1,455.63. The company has a 50 day simple moving average of GBX 1,532.83 and a 200 day simple moving average of GBX 1,518.46.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.